| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dicrotophos |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Dicrotophos up-regulates the expression of DME MAT2A |
[1] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01119
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME MAT2A |
[2] |
| 2-butenal |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01122
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
2-butenal inhibits the expression of DME MAT2A |
[3] |
| Chloropicrin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Chloropicrin inhibits the expression of DME MAT2A |
[4] |
| Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde inhibits the expression of DME MAT2A |
[5], [6] |
| Nickel chloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01397
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Nickel chloride inhibits the expression of DME MAT2A |
[7] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME MAT2A |
[8], [9] |
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate inhibits the expression of DME MAT2A |
[6] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 up-regulates the expression of DME MAT2A |
[10] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Acetaldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00872
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Acetaldehyde inhibits the expression of DME MAT2A |
[11] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Quercitrin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01449
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Quercitrin induces the drug-metabolizing activity of DME MAT2A |
[12] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 11 Xenobiotics
|
| Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin inhibits the expression of DME MAT2A |
[13] |
| Copper sulfate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate up-regulates the expression of DME MAT2A |
[14] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME MAT2A |
[15] |
| Dexamethasone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dexamethasone up-regulates the expression of DME MAT2A |
[16] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME MAT2A |
[17] |
| Estradiol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol up-regulates the expression of DME MAT2A |
[18], [19] |
| Fenofibrate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Fenofibrate inhibits the expression of DME MAT2A |
[20] |
| Folic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00404
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Folic acid up-regulates the expression of DME MAT2A |
[16] |
| Leflunomide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Leflunomide inhibits the expression of DME MAT2A |
[21] |
| Methotrexate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Methotrexate inhibits the expression of DME MAT2A |
[22] |
| Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Tretinoin inhibits the drug-metabolizing activity of DME MAT2A |
[23] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| 4-phenylbutyric acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00584
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2/3 |
| DME Modulation |
4-phenylbutyric acid inhibits the expression of DME MAT2A |
[24] |
| Ethanol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Ethanol inhibits the expression of DME MAT2A |
[25] |
| MeIQx |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00609
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MeIQx up-regulates the expression of DME MAT2A |
[2] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 inhibits the expression of DME MAT2A |
[26] |
|
|
|
|
|
|